(Q74262283)
Statements
A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy (English)
P D Maguire
T V Samulski
L R Prosnitz
E L Jones
G L Rosner
B Powers
L W Layfield
D M Brizel
S P Scully
J M Harrelson